Mechanistic Insights on Localized to Metastatic Prostate Cancer Transition and Therapeutic Opportunities

Autor: Yu EM, Hwang MW, Aragon-Ching JB

Publikováno v: Research and Reports in Urology, Vol Volume 15, Pp 519-529 (2023)

Eun-mi Yu,1 Min Woo Hwang,2 Jeanny B Aragon-Ching1 1GU Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA, USA; 2Department of Internal Medicine, Inova Fairfax Hospital, Fairfax, VA, USACorrespondence: Jeanny B Aragon-Ching, Clinical Program

Externí odkaz: https://doaj.org/article/f0f60806c2824e679bd77cdc1e79079b

Advanced prostate cancer – patient survival and potential impact of enzalutamide and other emerging therapies

Autor: Patel NK, Finianos A, Whitaker KD, Aragon-Ching JB

Publikováno v: Therapeutics and Clinical Risk Management, Vol 2014, Iss default, Pp 651-664 (2014)

Nihar K Patel, Antoine Finianos, Kristen D Whitaker, Jeanny B Aragon-Ching Department of Medicine, Division of Hematology and Oncology, George Washington University Medical Center, Washington, DC, USA Abstract: The advent of exponential growth of nov

Externí odkaz: https://doaj.org/article/228373c6b5084f61a83fbaab34b4bafe

The role of angiogenesis inhibitors in prostate cancer.

Autor: Aragon-Ching JB, Dahut WL

Publikováno v: Cancer Journal; Jan/Feb2008, Vol. 14 Issue 1, p20-25, 6p

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial

Autor: Koji Kawai, Satoshi Nagamori, Katherine M Bell-McGuinn, Cristiano Ferrario, Wen Pin Su, Isabel Syndikus, Aude Flechon, Georgios Gakis, Timothy Dudley Clay, Leticia Vazquez Cortés, Ronald de Wit, Florence Joly, Bozena Sikora-Kupis, Sergio Bracarda, Astra M. Liepa, Annemie Rutten, Daniel P. Petrylak, Su Peng Yeh, Annamaria Zimmermann, Sameera R. Wijayawardana, Mutsushi Kawakita, Siobhan Ng, Thean Hsiang Tan, Chikara Ohyama, Yu Jung Kim, Yuriy Golovko, Dimitrios Mavroudis, Jian Ri Li, Reinoud J. B. Blaisse, Mustafa Erman, Francesca Russo, Catherine Becht, Anghel Adrian Udrea, Robert Huddart, Syed A. Hussain, Fransiscus L.G. Erdkamp, Satoshi Fukasawa, Francesco Massari, Motohide Uemura, Boris Alekseev, Irfan Cicin, Se Hoon Park, Marcello Tucci, Lajos Géczi, Maureen J.B. Aarts, Yu Li Su, Fumimasa Fukuta, Hyo Jin Lee, Wolfgang Schultze-Seemann, Alexandra Drakaki, Hakan Harputluoglu, Xavier Garcia del Muro, Santhanam Sundar, Avivit Peer, Herlinde Dumez, William E. Lawler, Juan Ignacio Delgado Mignorance, Naveed Sarwar, Jeanny B. Aragon-Ching, Benjamin T. Herms, Fredrik Laestadius, Nobuaki Matsubara, Ivan Sinielnikov, Cora N. Sternberg, Hiroyuki Nishiyama, Piotr Tomczak, Brigitte Laguerre, Rebecca R. Hozak, Vasilis Karavasilis, Christina A. Schwentner, Hiroyuki Tsunemori, Masayoshi Nagata, Igor Bondarenko, Andrea Necchi, Yen Chuan Ou, Scott T. Tagawa, Constance Thibault, Richard A. Walgren, Akira Yokomizo, Evan Y. Yu, Alejo Rodriguez-Vida, Sufia Safina, Ulka N. Vaishampayan, János Révész, Aristotelis Bamias, Jae-Lyun Lee, Chien Liang Lin, Thomas W. Flaig, Roman Fomkin, Petr Alexandrovich Karlov, Joanna Wojcik-Tomaszewska, Junichi Inokuchi, Wataru Obara, Haralambos Kalofonos, John D. Hainsworth, Marc-Oliver Grimm, Thomas Eugene Lowe, Pablo Gajate Borau, Simon J. Crabb, Lisa Sengeloev, Junji Yonese, Simon Chowdhury, Elizabeth Jane Hovey, Daniel Castellano, Peter Istvan Acs, Chia-Chi Lin, Claudia Lorena Urzua Flores, Jean-Pascal Machiels, Kim N. Chi, Takahiro Osawa, Nobuo Shinohara, Daniel Kejzman, Günter Niegisch, David Sarid, Yuksel Urun, Yun Gyoo Lee, Oday Hamid, Alina Amalia Herzal, Michael Schenker, Eli Rosenbaum, Enrique Grande, Raya Leibowitz-Amit, Naoto Miyajima, Michiel S. van der Heijden, Shinichi Yamashita, Susanna Yee Shan Cheng, Kazuo Nishimura, Sun Young Rha, Thomas Powles, Hasan Şenol Coşkun, Jens Bedke, Ivor J. Percent, Christos Papandreou, James K. Schwarz, Masafumi Oyama, Giorgio V. Scagliotti, Chong-Xian Pan, Yoshihiko Tomita, Giampaolo Tortora, Stéphane Culine, Suet Lai Shirley Wong, Andrey Semenov, Jennifer L. Cultrera, Niels Viggo Jensen, Michael Stöckle, Katsuyoshi Hashine

Publikováno v: Lancet Oncology, 21(1), 105-120. Lancet Publishing Group
The Lancet. Oncology, Vol. 21, no.1, p. 105-120 (2020)
Lancet oncology, 21(1), 105-120. Elsevier Science
lancet oncology, 21(1), 105-120. Lancet Publishing Group

Background Ramucirumab-an IgG1 vascular endothelial growth factor receptor 2 antagonistplus docetaxel was previously reported to improve progression-free survival in platinum-refractory, advanced urothelial carcinoma. Here, we report the secondary en

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf61e6c114a1ba3c5764d0e77ad9425a
https://doi.org/10.1016/s1470-2045(19)30668-0

Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.

Autor: Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, USA., Gratzke C; Department of Urology, University Hospital Freiburg, Freiburg, Germany., Feyerabend S; Studienpraxis Urologie, Nürtingen, Germany., Werbrouck P; Department of Urology, AZ Groeninge, Kortrijk, Belgium., Carles J; Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Vjaters E; Urological Center, Pauls Stradiņš Clinical University Hospital, Riga, Latvia., Tammela TLJ; Department of Urology, Tampere University Hospital and Tampere University, Tampere, Finland., Morris D; Urology Associates, PC, Nashville, TN, USA., Aragon-Ching JB; Inova Schar Cancer Institute, Fairfax, VA, USA., Concepcion RS; Urology Associates, PC, Nashville, TN, USA., Emmenegger U; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Fleshner N; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Grabbert M; Department of Urology, University Hospital Freiburg, Freiburg, Germany., Lietuvietis V; Urology Clinic, Department of Surgery, Riga East Clinical University Hospital, Riga, Latvia., Mahammedi H; Medical Oncology, Jean Perrin Center, Clermont-Ferrand, France., Cruz FM; Núcleo de Ensino e Pesquisa da Rede São Camilo, São Paulo, Brazil., Paula A; Oncologic Surgery, Hospital Araújo Jorge, Goiânia, Brazil., Pieczonka C; Associated Medical Professionals, Syracuse, NY, USA., Rannikko A; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Richardet M; Oncologic Institute of Córdoba, Sanatorio Aconcagua, Córdoba, Argentina., Silveira G; Centro Oncológico do Triângulo, Uberlândia, Brazil., Kuss I; Bayer AG, Berlin, Germany., Le Berre MA; Bayer HealthCare SAS, Loos, France., Verholen F; Bayer Consumer Care AG, Basel, Switzerland., Sarapohja T; Orion Pharma, Espoo, Finland., Smith MR; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Fizazi K; Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France.

Publikováno v: The oncologist [Oncologist] 2024 Jul 05; Vol. 29 (7), pp. 581-588.